TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
BOARD OF MEDICINE
Fast-Track Regulation
Title of Regulation: 18VAC85-50. Regulations Governing the Practice of Physician Assistants (amending 18VAC85-50-10, 18VAC85-50-35, 18VAC85-50-56, 18VAC85-50-59, 18VAC85-50-61, 18VAC85-50-101, 18VAC85-50-115, 18VAC85-50-178; repealing 18VAC85-50-30, 18VAC85-50-116, 18VAC85-50-180, 18VAC85-50-181, 18VAC85-50-182).
Statutory Authority: § 54.1-2400 of the Code of Virginia.
Public Hearing Information: No public hearing is currently scheduled.
Public Comment Deadline: July 2, 2025.
Effective Date: July 17, 2025.
Agency Contact: Erin Barrett, Director of Legislative and Regulatory Affairs, Department of Health Professions, Perimeter Center, 9960 Mayland Drive, Suite 300, Henrico, VA 23233, telephone (804) 750-3912, FAX (804) 915-0382, or email erin.barrett@dhp.virginia.gov.
Basis: Section 54.1-2400 of the Code of Virginia authorizes the Board of Medicine to promulgate regulations to administer the regulatory system. Section 54.1-2951.1 of the Code of Virginia requires the Board of Medicine to license and regulate physician assistants.
Purpose: The elimination of redundant provisions and reduction of barriers to licensure generally protect the health, safety, and welfare of citizens by ensuring a sufficient workforce of physician assistants.
Rationale for Using Fast-Track Rulemaking Process: The impetus for these amendments were the board's 2022 periodic review of this chapter. This action is noncontroversial and appropriate for the fast-track rulemaking process because the changes remove or modify provisions that are redundant of statutory requirements, are not related to physician assistants, are outdated, or are otherwise ineffectual.
Substance: The amendments (i) remove duplicate provisions and redundant or unnecessary language, including outdated definitions, public participation provisions, reduced fees from prior years, language related to vitamins, anabolic steroids, and weight loss pharmacotherapy, and continuing education requirements for restricted volunteer licenses; (ii) remove fees for voluntary out-of-state practice; and (iii) consolidate information related to informed consent for office-based procedures.
Issues: There are no primary advantages or disadvantages to the public. There are no primary advantages or disadvantages to the agency or the Commonwealth.
Department of Planning and Budget Economic Impact Analysis:
The Department of Planning and Budget (DPB) has analyzed the economic impact of this proposed regulation in accordance with § 2.2-4007.04 of the Code of Virginia and Executive Order 19. The analysis presented represents DPB's best estimate of the potential economic impacts as of the date of this analysis.1
Summary of the Proposed Amendments to Regulation. As a result of a 2022 periodic review2 and in response to Executive Order 19 (2022)3 (EO 19), the Board of Medicine (board) is proposing to eliminate a $10 registration fee for out-of-state volunteers along with numerous editorial updates to this regulation governing physician assistants.
Background. As a result of the 2022 periodic review and in order to reduce regulatory requirements as directed by EO 19, the board proposes to eliminate a $10 registration fee for out-of-state volunteers, revise or delete language that duplicates statutory requirements, and eliminate provisions that are no longer needed. The affected regulatory language pertains to deletion of a $10 fee for voluntary out-of-state practice; unused definitions; public participation guidelines; reduced fees for previous years; minor edits; removal of continuing education language for restricted volunteer licenses; deletion of duplicative provisions regarding volunteer restricted licenses; consolidation of information related to informed consent for office-based procedures and subsequently elimination of redundant or extraneous language; and elimination of language related to vitamins, minerals, food supplements, amphetamine, controlled substances, and anabolic steroids.
Estimated Benefits and Costs: The only proposed change that would depart from current practice is the elimination of a $10 registration fee collected from out-of-state physician assistants volunteering in Virginia. The board states that the fee is so minimal and used so infrequently that its elimination will have virtually no effect on board funds. In recent history spanning over several years, this fee was collected only once from a single applicant. Therefore, the elimination of this fee is not expected to have a significant impact on the board. Moreover, the elimination of this fee may encourage volunteering activities by out-of-state physician assistants in Virginia should the need arise. One change that appears to depart from current practice, but in fact does not, is the elimination of a requirement that individuals who renew a restricted volunteer license obtain 50 hours of continuing education per biennium. However, the board states that it is unreasonable to impose a continuing education requirement on restricted volunteer licenses when there is no such requirement for full licensees. Consequently, the board has not been enforcing this requirement. Therefore, the removal of this regulatory text is not expected to create any effect other than accurately reflecting board continuing education expectations for individuals with restricted volunteer licenses. The board states, and it so appears, that all of the remaining proposed changes to this regulation are editorial in nature and would not affect the practice of physician assistants. For example, removing duplicative or redundant references, such as to the public participation regulation; elimination of language regarding vitamins, minerals, or food supplements; removal of language regarding the prescription of amphetamine, controlled substances and anabolic steroids would not make this regulation any less enforceable or applicable because these requirements are still enforceable under more general provisions. However, to the extent that physician assistants and other members of the public relied upon these regulatory provisions to better understand the requirements that pertain to physician assistants, some lack of clarity about these requirements may result.
Businesses and Other Entities Affected. As of June 30, 2022, there were 5,524 individuals licensed as physician assistants that are subject to this regulation. However, the board has no data regarding any potential applicants for voluntary physician assistant licenses. Historically, the applications for volunteer licenses have been infrequent. Looking over the data over the past several years, the board has identified a single license issued to a practitioner from out of state who was volunteering in Virginia. The Code of Virginia requires DPB to assess whether an adverse impact may result from the proposed regulation.4 An adverse impact is indicated if there is any increase in net cost or reduction in net revenue for any entity, even if the benefits exceed the costs for all entities combined. The proposed changes are not expected to create any significant economic impact. No adverse impact on any entity is indicated nor a disproportionate impact is expected.
Small Businesses5 Affected.6 The proposed amendments do not appear to adversely affect small businesses.
Localities7 Affected.8 The proposed amendments do not disproportionally affect any localities, nor introduce costs for local governments.
Projected Impact on Employment. The proposed amendments do not affect employment.
Effects on the Use and Value of Private Property. No impact on the use and value of private property nor real estate development costs is expected.
_____________________________
1 Section 2.2-4007.04 of the Code of Virginia requires that such economic impact analyses determine the public benefits and costs of the proposed amendments. Further the analysis should include but not be limited to: (1) the projected number of businesses or other entities to whom the proposed regulatory action would apply, (2) the identity of any localities and types of businesses or other entities particularly affected, (3) the projected number of persons and employment positions to be affected, (4) the projected costs to affected businesses or entities to implement or comply with the regulation, and (5) the impact on the use and value of private property.
2 https://townhall.virginia.gov/l/ViewPReview.cfm?PRid=2149.
3 https://townhall.virginia.gov/EO-19-Development-and-Review-of-State-Agency-Regulations.pdf.
4 Pursuant to § 2.2-4007.04 D: In the event this economic impact analysis reveals that the proposed regulation would have an adverse economic impact on businesses or would impose a significant adverse economic impact on a locality, business, or entity particularly affected, the Department of Planning and Budget shall advise the Joint Commission on Administrative Rules, the House Committee on Appropriations, and the Senate Committee on Finance. Statute does not define "adverse impact," state whether only Virginia entities should be considered, nor indicate whether an adverse impact results from regulatory requirements mandated by legislation.
5 Pursuant to § 2.2-4007.04, small business is defined as "a business entity, including its affiliates, that (i) is independently owned and operated and (ii) employs fewer than 500 full-time employees or has gross annual sales of less than $6 million."
6 If the proposed regulatory action may have an adverse effect on small businesses, § 2.2-4007.04 requires that such economic impact analyses include: (1) an identification and estimate of the number of small businesses subject to the proposed regulation, (2) the projected reporting, recordkeeping, and other administrative costs required for small businesses to comply with the proposed regulation, including the type of professional skills necessary for preparing required reports and other documents, (3) a statement of the probable effect of the proposed regulation on affected small businesses, and (4) a description of any less intrusive or less costly alternative methods of achieving the purpose of the proposed regulation. Additionally, pursuant to § 2.2-4007.1 of the Code of Virginia, if there is a finding that a proposed regulation may have an adverse impact on small business, the Joint Commission on Administrative Rules shall be notified.
7 "Locality" can refer to either local governments or the locations in the Commonwealth where the activities relevant to the regulatory change are most likely to occur.
8 Section 2.2-4007.04 defines "particularly affected" as bearing disproportionate material impact.
Agency Response to Economic Impact Analysis: The Board of Medicine concurs with the economic impact analysis prepared by the Department of Planning and Budget.
Summary:
As a result of a 2022 periodic review, the amendments (i) remove duplicate provisions and redundant or unnecessary language, including outdated definitions; public participation provisions; reduced fees from prior years; language related to vitamins, anabolic steroids, and weight loss pharmacotherapy; and continuing education requirements for restricted volunteer licenses; (ii) remove fees for voluntary out-of-state practice; and (iii) consolidate information related to informed consent for office-based procedures.
18VAC85-50-10. Definitions.
A. The following words and terms shall have the meanings ascribed to them in § 54.1-2900 of the Code of Virginia:
"Board."
"Collaboration."
"Consultation."
"Patient care team physician."
"Patient care team podiatrist."
"Physician assistant."
B. The following words and terms when used in this chapter shall have the following meanings unless the context clearly indicates otherwise:
"Group practice" means the practice of a group of two or more doctors of medicine, osteopathy, or podiatry licensed by the board who practice as a partnership or professional corporation.
"Institution" means a hospital, nursing home or other health care facility, community health center, public health center, industrial medicine or corporation clinic, a medical service facility, student health center, or other setting approved by the board.
"NCCPA" means the National Commission on Certification of Physician Assistants.
"Practice agreement" means a written or electronic agreement developed by one or more patient care team physicians or podiatrists and the physician assistant that defines the relationship between the physician assistant and the physicians or podiatrists, the prescriptive authority of the physician assistant, and the circumstances under which a physician or podiatrist will see and evaluate the patient.
18VAC85-50-30. Public participation guidelines. (Repealed.)
A separate board regulation, 18VAC85-11, provides for involvement of the public in the development of all regulations of the Virginia Board of Medicine.
18VAC85-50-35. Fees.
Unless otherwise provided, the following fees shall not be refundable:
1. The initial application fee for a license, payable at the time application is filed, shall be $130.
2. The biennial fee for renewal of an active license shall be $135 and for renewal of an inactive license shall be $70, payable in each odd-numbered year in the birth month of the licensee. For 2021, the fee for renewal of an active license shall be $108, and the fee for renewal of an inactive license shall be $54.
3. The additional fee for late renewal of licensure within one renewal cycle shall be $50.
4. A restricted volunteer license issued pursuant to § 54.1-2951.3 of the Code of Virginia shall expire 12 months from the date of issuance and may be renewed without charge by receipt of a renewal application that verifies that the physician assistant continues to comply with provisions of § 54.1-2951.3 of the Code of Virginia.
5. The fee for reinstatement of a license pursuant to § 54.1-2408.2 of the Code of Virginia shall be $2,000.
6. The fee for a duplicate license shall be $5.00, and the fee for a duplicate wall certificate shall be $15.
7. The handling fee for a returned check or a dishonored credit card or debit card shall be $50.
8. The fee for a letter of good standing or verification to another jurisdiction shall be $10.
9. The fee for an application or for the biennial renewal of a restricted volunteer license pursuant to 18VAC85-50-61 shall be $35, due in the licensee's birth month. An additional fee for late renewal of licensure shall be $15 for each renewal cycle.
Part II
Requirements for Practice as a Physician's Physician Assistant
18VAC85-50-56. Renewal of license.
A. Every licensed physician assistant intending to continue to practice shall biennially renew the license in each odd numbered year in the licensee's birth month by:
1. Returning the renewal form and fee as prescribed by the board; and
2. Verifying compliance with continuing medical education standards established by the NCCPA.
B. Any No physician assistant who allows his a NCCPA certification to lapse shall be considered not licensed by the board. Any such physician assistant who proposes to resume his practice shall make a new application for licensure.
18VAC85-50-59. Registration for voluntary practice by out-of-state licensees.
Any physician assistant who does not hold a license to practice in Virginia and who seeks registration to practice under subdivision 27 of § 54.1-2901 of the Code of Virginia on a voluntary basis under the auspices of a publicly supported, all volunteer, nonprofit organization that sponsors the provision of health care to populations of underserved people shall:
1. File a complete application for registration on a form provided by the board at least five business days prior to engaging in such practice. An No incomplete application will not be considered;
2. Provide a complete record of professional licensure in each state in which he the physician assistant has held a license and a copy of any current license;
3. Provide the name of the nonprofit organization, and the dates and location of the voluntary provision of services; and
4. Pay a registration fee of $10; and
5. 4. Provide a notarized statement from a representative of the nonprofit organization attesting to its the organization's compliance with provisions of subdivision 27 of § 54.1-2901 of the Code of Virginia.
18VAC85-50-61. Restricted volunteer license.
A. A physician assistant who held an unrestricted license issued by the Virginia Board of Medicine or by a board in another state as a licensee in good standing at the time the license expired or became inactive may be issued a restricted volunteer license to practice without compensation in a clinic that is organized in whole or in part for the delivery of health care services without charge in accordance with § 54.1-106 of the Code of Virginia.
B. To be issued a restricted volunteer license, a physician assistant shall submit an application to the board that documents compliance with requirements of § 54.1-2928.1 of the Code of Virginia and the application fee prescribed in 18VAC85-50-35.
C. The licensee who intends to continue practicing with a restricted volunteer license shall renew biennially during his the licensee's birth month, meet the continued competency requirements prescribed in subsection D of this section, and pay to the board the renewal fee prescribed in 18VAC85-50-35.
D. The holder of a restricted volunteer license shall not be required to attest to hours of continuing education for the first renewal of such a license. For each renewal thereafter, the licensee shall attest to obtaining 50 hours of continuing education during the biennial renewal period with at least 25 hours in Type 1 and no more than 25 hours in Type 2 as acceptable to the NCCPA.
18VAC85-50-101. Requirements for a practice agreement.
A. Prior to initiation of practice, a physician assistant and one or more patient care team physicians or podiatrists shall enter into a written or electronic practice agreement that spells out the roles and functions of the physician assistant and is consistent with provisions of § 54.1-2952 of the Code of Virginia.
1. Any such practice agreement shall take into account such factors as the physician assistant's level of competence, the number of patients, the types of illness treated by the physicians or podiatrists, the nature of the treatment, special procedures, and the nature of the physician's or podiatrist's availability in ensuring direct physician or podiatrist involvement at an early stage and regularly thereafter.
2. The practice agreement shall also provide an evaluation process for the physician assistant's performance, including a requirement specifying the time period, proportionate to the acuity of care and practice setting, within which the physicians or podiatrists shall review the record of services rendered by the physician assistant.
3. The practice agreement may include requirements for periodic site visits by licensees who supervise and direct the patient care team physicians or podiatrists to collaborate and consult with physician assistants who provide services at a location other than where the physicians or podiatrists regularly practice.
B. The board may require information regarding the degree of collaboration and consultation by the patient care team physicians or podiatrists. The board may also require a patient care team physician or podiatrist to document the physician assistant's competence in performing such tasks.
C. If the role of the physician assistant includes prescribing drugs and devices, the written practice agreement shall include those schedules and categories of drugs and devices that are within the scope of practice and proficiency of the patient care team physicians or podiatrists.
D. If the initial practice agreement did not include prescriptive authority, there shall be an addendum to the practice agreement for prescriptive authority.
E. If there are any changes in consultation and collaboration, authorization, or scope of practice, a revised practice agreement shall be entered into at the time of the change.
F. Physician assistants appointed as medical examiners pursuant to § 32.1-282 of the Code of Virginia may practice without a written or electronic practice agreement.
G. Physician assistants employed by (i) a hospital as defined by § 32.1-123 of the Code of Virginia, (ii) a state facility as defined by § 37.2-100 of the Code of Virginia, or (iii) a federally qualified health center designated by the Centers for Medicare and Medicaid Services may practice without a written or electronic practice agreement consistent with the requirements contained in § 54.1-2951.1 E of the Code of Virginia.
18VAC85-50-115. Responsibilities of the physician assistant.
A. The physician assistant shall not render independent health care and shall:
1. Perform only those medical care services that are within the scope of the practice and proficiency of the patient care team physicians or podiatrists as prescribed in the physician assistant's practice agreement. When a physician assistant is working outside the scope of specialty of the patient care team physicians or podiatrists, then the physician assistant's functions shall be limited to those areas not requiring specialized clinical judgment, unless a separate practice agreement has been executed for an alternate patient care team physician or podiatrist.
2. Prescribe only those drugs and devices as allowed in Part V (18VAC85-50-130 et seq.) of this chapter.
3. Wear during the course of performing his physician assistant duties identification showing clearly that he is status as a physician assistant.
B. If, due to illness, vacation, or unexpected absence, a patient care team physician or podiatrist or alternate physician or podiatrist is unable to supervise the activities of his collaborate or consult with the physician assistant, such patient care team physician or podiatrist may temporarily delegate the responsibility to another doctor of medicine, osteopathic medicine, or podiatry.
Temporary coverage may not exceed four weeks unless special permission is granted by the board.
C. With respect to physician assistants employed by institutions, the following additional regulations provisions shall apply:
1. No physician assistant may render care to a patient unless the physician or podiatrist responsible for that patient is available for collaboration and consultation with that physician assistant.
2. Any such practice agreement as described in subdivision A 1 of this subsection section shall delineate the duties which said that the patient care team physician or podiatrist authorizes the physician assistant to perform.
D. Practice by a physician assistant in a hospital, including an emergency department, shall be in accordance with § 54.1-2952 of the Code of Virginia.
18VAC85-50-116. Volunteer restricted license for certain physician assistants. (Repealed.)
The issuance of a volunteer restricted license and the practice of a physician assistant under such a license shall be in accordance with the provisions of § 54.1-2951.3 of the Code of Virginia.
18VAC85-50-178. Practitioner-patient communication.
A. Except as provided in § 32.1-127.1:03 F of the Code of Virginia, a practitioner shall accurately inform a patient or his the patient's legally authorized representative of his the patient's medical diagnoses, prognosis, and prescribed treatments or plans of care in understandable terms. A No practitioner shall not deliberately make a false or misleading statement regarding the practitioner's skill or the efficacy or value of a medication, treatment, or procedure prescribed or directed by the practitioner in the treatment of any disease or condition.
B. A practitioner shall present information relating to the patient's care to a patient or his legally authorized representative in understandable terms and encourage participation in the decisions regarding the patient's care and shall refer to or consult with other health care professionals if so indicated.
C. B. Before surgery or any invasive procedure is performed, informed consent shall be obtained from the patient in accordance with the policies of the health care entity. Practitioners shall inform patients of the risks, benefits, and alternatives of the recommended surgery or invasive procedure that a reasonably prudent practitioner in similar practice in Virginia would tell a patient.
1. In the instance of a minor or a patient who is incapable of making an informed decision on his the minor's or patient's own behalf or is incapable of communicating such a decision due to a physical or mental disorder, the legally authorized person available to give consent shall be informed and the consent documented.
2. An exception to the requirement for consent prior to performance of surgery or an invasive procedure may be made in an emergency situation when a delay in obtaining consent would likely result in imminent harm to the patient.
3. For the purposes of this provision, "invasive procedure" means any diagnostic or therapeutic procedure performed on a patient that is not part of routine, general care and for which the usual practice within the health care entity is to document specific informed consent from the patient or surrogate decision maker prior to proceeding.
18VAC85-50-180. Vitamins, minerals and food supplements. (Repealed.)
A. The recommendation or direction for the use of vitamins, minerals or food supplements and the rationale for that recommendation shall be documented by the practitioner. The recommendation or direction shall be based upon a reasonable expectation that such use will result in a favorable patient outcome, including preventive practices, and that a greater benefit will be achieved than that which can be expected without such use.
B. Vitamins, minerals, or food supplements, or a combination of the three, shall not be sold, dispensed, recommended, prescribed, or suggested in doses that would be contraindicated based on the individual patient's overall medical condition and medications.
C. The practitioner shall conform to the standards of his particular branch of the healing arts in the therapeutic application of vitamins, minerals or food supplement therapy.
18VAC85-50-181. Pharmacotherapy for weight loss. (Repealed.)
A. A practitioner shall not prescribe amphetamine, Schedule II, for the purpose of weight reduction or control.
B. A practitioner shall not prescribe controlled substances, Schedules III through VI, for the purpose of weight reduction or control in the treatment of obesity, unless the following conditions are met:
1. An appropriate history and physical examination are performed and recorded at the time of initiation of pharmacotherapy for obesity by the prescribing physician, and the physician reviews the results of laboratory work, as indicated, including testing for thyroid function;
2. If the drug to be prescribed could adversely affect cardiac function, the physician shall review the results of an electrocardiogram performed and interpreted within 90 days of initial prescribing for treatment of obesity;
3. A diet and exercise program for weight loss is prescribed and recorded;
4. The patient is seen within the first 30 days following initiation of pharmacotherapy for weight loss, by the prescribing physician or a licensed practitioner with prescriptive authority working under the supervision of the prescribing physician, at which time a recording shall be made of blood pressure, pulse, and any other tests as may be necessary for monitoring potential adverse effects of drug therapy; and
5. The treating physician shall direct the follow-up care, including the intervals for patient visits and the continuation of or any subsequent changes in pharmacotherapy. Continuation of prescribing for treatment of obesity shall occur only if the patient has continued progress toward achieving or maintaining a target weight and has no significant adverse effects from the prescribed program.
C. If specifically authorized in his practice agreement with a patient care team physician, a physician assistant may perform the physical examination, review tests, and prescribe Schedules III through VI controlled substances for treatment of obesity as specified in subsection B of this section.
18VAC85-50-182. Anabolic steroids. (Repealed.)
A physician assistant shall not prescribe or administer anabolic steroids to any patient for other than accepted therapeutic purposes.
VA.R. Doc. No. R25-7379; Filed May 01, 2025